Maternal and fetal outcomes of pregnancy occurring after a diagnosis of immune-mediated thrombotic thrombocytopenic purpura

• Published in: Annals of hematology Vol. 101; no. 10; pp. 2159 - 2167
• Main Authors: Brown, Jenna, Potugari, Bindu, Mazepa, Marshall A., Kohli, Ruhail, Moliterno, Alison R., Brodsky, Robert A., Vaught, Jason A., Burwick, Richard, Chaturvedi, Shruti
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.10.2022; Springer Nature B.V
• Subjects: ADAMTS13 Protein; Female; HELLP Syndrome - diagnosis; Hematology; Humans; Medical diagnosis; Medicine; Medicine & Public Health; Oncology; Original Article; Pre-Eclampsia - diagnosis; Pre-Eclampsia - epidemiology; Preeclampsia; Pregnancy; Purpura; Purpura, Thrombocytopenic, Idiopathic; Purpura, Thrombotic Thrombocytopenic - diagnosis; Purpura, Thrombotic Thrombocytopenic - therapy; Recurrence; Retrospective Studies; Pregnancy; Thrombotic thrombocytopenic purpura; ADAMTS13; Preeclampsia
• ISSN: 0939-5555; 1432-0584
• DOI: 10.1007/s00277-022-04936-2

Pregnancy is a well-established trigger for a first episode or relapse of immune thrombotic thrombocytopenic purpura (iTTP). Other outcomes of subsequent pregnancy after a diagnosis of iTTP are less well described. We conducted this retrospective cohort study to evaluate maternal and fetal outcomes of pregnancy in women with prior iTTP from the Johns Hopkins Thrombotic Microangiopathy Cohort. Of 168 women in the cohort, 102 were of reproductive age at diagnosis. Fourteen pregnancies (in 9 women) that occurred after the initial iTTP episode were included in the analysis. iTTP relapse occurred in 9 (64%) pregnancies. Out of the 9 instances of relapse, 5 relapses occurred in 2 women. Seven pregnancies (50%) ended in fetal death or miscarriage in the setting of iTTP relapse and three were electively terminated due to fear of relapse. Four pregnancies (50% of the 8 that progressed beyond 20 weeks) were complicated by preeclampsia or HELLP syndrome, which is over ten-fold higher than that of the general population. No maternal deaths occurred. Only 4 pregnancies resulted in live births, of which, 2 were pre-term. Pregnancy in women with prior iTTP is associated with a substantial risk of iTTP relapse and fetal loss. Preeclampsia and HELLP syndrome is also more common than that in the general population. ADAMTS13 monitoring and preemptive therapy may improve pregnancy outcomes, which needs to be evaluated prospectively.